About Magdalena Krzystolik, MD

Dr. Magdalena G. Krzystolik is Site Director at Mass. Eye and Ear, Providence and Mass. Eye and Ear, Plainville (MA) where she specializes in the treatment and surgery of retinal diseases with clinical focus on diabetic retinopathy, retinal vein occlusions, age-related macular degeneration, and retinal detachments. Dr. Krzystolik's academic interests include anti-angiogenic treatments of retinal diseases, prevention of sport-related ocular trauma in children, and integrating retinal surgery into the ophthalmic graduate medical education curriculum.

Dr. Krzystolik received her MD from the Pritzker School of Medicine at the University of Chicago, followed by an ophthalmology residency at Harvard Medical School (HMS). Following graduation, she served as Chief Resident at Mass. Eye and Ear before completing a vitreoretinal fellowship there in 2000 as a Heed Fellow.

Dr. Krzystolik is a Member of the Faculty at Harvard Medical School, and a Clinical Associate Professor of Surgery at the Warren Alpert Medical School of Brown University where she lectures, supervises and mentors trainees, and conducts clinical research. She  is a member of several professional societies including the New England Ophthalmological Society, Massachusetts Society of Eye Physicians and Surgeons, the Rhode Island Society of Eye Physicians and Surgeons, and the American Academy of Ophthalmology.

Departments, Centers, & Programs:

Clinical Interests:




Mass. Eye and Ear at Providence
One Randall Square
Suite 203
Providence, RI 02904
Phone: 401-453-4600

Mass. Eye and Ear at Plainville
30 Man Mar Dr.
Suite 2
Plainville, MA 02762
Phone: 508-695-9550

Medical Education

  • MD, University of Chicago Pritzker School of Medicine
  • Residency, Massachusetts Eye and Ear***
  • Fellowship, Massachusetts Eye and Ear***

American Board Certifications

  • Ophthalmology, American Board of Ophthalmology

Accepted Insurance Plans

Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.


Dr. Krzystolik's research focuses on antiangiogenic treatments for retinal diseases and integrating retinal surgery into the ophthalmic graduate medical education curriculum.


  • 1. Solomon SD, Lindsley K, Vedula SS, Krzystolik MG, Hawkins BS. Anti-vascular endothelial growth factor for neovascular age-related macular degeneration. Cochrane Database Syst Rev. 2019 03 04; 3:CD005139.

    2. Li E, Greenberg PB, Voruganti I, Krzystolik MG. Cost and Selection of Ophthalmic Anti-Vascular Endothelial Growth Factor Agents. R I Med J (2013). 2016 May 02; 99(5):15-7. 

    3. Solomon SD, Lindsley KB, Krzystolik MG, Vedula SS, Hawkins BS. Intravitreal Bevacizumab Versus Ranibizumab for Treatment of Neovascular Age-Related Macular Degeneration: Findings from a Cochrane Systematic Review. Ophthalmology. 2016 Jan; 123(1):70-77.e1.

    4. Callahan AB, Skondra D, Krzystolik M, Yonekawa Y, Eliott D. Wyburn-Mason Syndrome Associated With Cutaneous Reactive Angiomatosis and Central Retinal Vein Occlusion. Ophthalmic Surg Lasers Imaging Retina. 2015 Jul-Aug; 46(7):760-2.

    5. Li E, Greenberg PB, Krzystolik MG. Nurse-administered intravitreal injections: a systematic review. Graefes Arch Clin Exp Ophthalmol. 2015 Sep; 253(9):1619-21.

    View more

Reviews: Comments and Ratings